1. Home
  2. OCUP vs CRWS Comparison

OCUP vs CRWS Comparison

Compare OCUP & CRWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUP
  • CRWS
  • Stock Information
  • Founded
  • OCUP 2018
  • CRWS 1957
  • Country
  • OCUP United States
  • CRWS United States
  • Employees
  • OCUP N/A
  • CRWS N/A
  • Industry
  • OCUP Biotechnology: Pharmaceutical Preparations
  • CRWS Textiles
  • Sector
  • OCUP Health Care
  • CRWS Consumer Discretionary
  • Exchange
  • OCUP Nasdaq
  • CRWS Nasdaq
  • Market Cap
  • OCUP 53.1M
  • CRWS 49.2M
  • IPO Year
  • OCUP N/A
  • CRWS N/A
  • Fundamental
  • Price
  • OCUP $1.27
  • CRWS $4.84
  • Analyst Decision
  • OCUP Strong Buy
  • CRWS
  • Analyst Count
  • OCUP 3
  • CRWS 0
  • Target Price
  • OCUP $18.67
  • CRWS N/A
  • AVG Volume (30 Days)
  • OCUP 92.8K
  • CRWS 16.1K
  • Earning Date
  • OCUP 11-11-2024
  • CRWS 11-13-2024
  • Dividend Yield
  • OCUP N/A
  • CRWS 6.64%
  • EPS Growth
  • OCUP N/A
  • CRWS N/A
  • EPS
  • OCUP N/A
  • CRWS 0.41
  • Revenue
  • OCUP $16,449,000.00
  • CRWS $86,721,000.00
  • Revenue This Year
  • OCUP N/A
  • CRWS N/A
  • Revenue Next Year
  • OCUP $258.69
  • CRWS N/A
  • P/E Ratio
  • OCUP N/A
  • CRWS $11.70
  • Revenue Growth
  • OCUP N/A
  • CRWS 13.41
  • 52 Week Low
  • OCUP $1.15
  • CRWS $4.11
  • 52 Week High
  • OCUP $3.50
  • CRWS $5.97
  • Technical
  • Relative Strength Index (RSI)
  • OCUP 44.79
  • CRWS 55.51
  • Support Level
  • OCUP $1.24
  • CRWS $4.76
  • Resistance Level
  • OCUP $1.34
  • CRWS $4.90
  • Average True Range (ATR)
  • OCUP 0.08
  • CRWS 0.06
  • MACD
  • OCUP 0.00
  • CRWS 0.01
  • Stochastic Oscillator
  • OCUP 12.00
  • CRWS 62.60

About OCUP Ocuphire Pharma Inc.

Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting the front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema.

About CRWS Crown Crafts Inc

Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.

Share on Social Networks: